Mara Rejane Ritter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mara Rejane Ritter has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Anderson Luiz Christ
Universidade Federal do Paraná; Centro Politécnico; Museu de Ciências Naturais; ZIP Code 81531-980; Curitiba; Paraná; Brazil
3 shared publications - Ulysses Paulino Albuquerque
Laboratório de Ecologia e Evolução de Sistemas Socioecológicos, Centro de Biociências, Departamento de Botânica, Universidade Federal de Pernambuco, Recife, Brazil
3 shared publications - Eduardo Luis Konrath
Postgraduate Program in Pharmaceutical Science, Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul (UFRGS), Brazil
2 shared publications - Jimi Naoki Nakajima
Instituto de Biologia, Universidade Federal de Uberlândia, Uberlândia, Brazil
2 shared publications Adriana Morais Aita
Universidade Federal do Rio Grande do Sul, Porto Alegre, Brasil
1 shared publication- Adriane Lindemann
Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre 90160-093, RS, Brazil., Brazil
1 shared publication
Latest Publications
- 9 September 2026
- Published by Magnolia Press in Phytotaxa
- Vol. 773 (3) , 271-280
Grazielia alpestris (Asteraceae, Eupatorieae), a new combination for a species from South and Southeastern highlands of Brazil
A new combination of Grazielia (Asteraceae, Eupatorieae), endemic to the highlands of the Brazilian Atlantic Forest, is proposed here. The genus is characterized by having one series of outer phyllaries noticeably different from the inner ones. The species in question shows similarities with G. gaudichaudiana, G. intermedia and G. serrata, but differs from these in narrowly elliptic to lanceolate leaf blades and glabrous leaves. An updated identification key for the genus is presented. We also provide data on etymology and flowering period, photographic plates, and a preliminary extinction risk assessment for the taxon.
- 9 September 2026
- Published by Magnolia Press in Phytotaxa
- Vol. 773 (3) , 271-280
Grazielia alpestris (Asteraceae, Eupatorieae), a new combination for a species from South and Southeastern highlands of Brazil
A new combination of Grazielia (Asteraceae, Eupatorieae), endemic to the highlands of the Brazilian Atlantic Forest, is proposed here. The genus is characterized by having one series of outer phyllaries noticeably different from the inner ones. The species in question shows similarities with G. gaudichaudiana, G. intermedia and G. serrata, but differs from these in narrowly elliptic to lanceolate leaf blades and glabrous leaves. An updated identification key for the genus is presented. We also provide data on etymology and flowering period, photographic plates, and a preliminary extinction risk assessment for the taxon.
- Open Access
- 18 March 2025
- Published by MDPI AG in Preprints.org
Development of Monteverdia ilicifolia Spray-Dried Extract for a Clinical Trial: A Successful Scale-Up Experience with a Brazilian Native Plant
Background/Objectives: Our group has been trying to bring scientific rationale to the quality, safety and efficacy of Brazilian medicinal plants. This work was the first step of a broader project evaluating the potential of Monteverdia ilicifolia capsules for managing dyspepsia in a randomized, double-blind clinical trial. M. ilicifolia is a native species widely used in Brazilian traditional medicine for treating gastric disturbances. The central aim of the present work was to develop capsules containing an M. ilicifolia standardized spray-dried extract (SDP) on a lab scale and to transfer the process to a Brazilian pharmaceutical industry for a scale-up approach, achieving high-quality capsule production for our clinical trial Methods: Quality control of raw materials and derivative products followed the official plant monograph, specifically total tannin content (Folin-Dennis method) and epicatechin content (HPLC analysis). The leaves of M. ilicifolia were used to prepare an infusion for 15 minutes. The infusion was filtered and concentrated, and cornstarch and colloidal silicon dioxide were added to produce a M. illicifolia spray-dried powder, which was subsequently encapsulated. Results: The raw material and SDP had high total tannins and epicatechin content. The number of capsules required to achieve 860 mg of SDP was three capsules size 0. Due to the blind tests, the dose of 400 mg and the omeprazole (20 mg) were also encapsulated in three capsules size 0. The capsules prepared on a semi-industrial scale showed an immediate release profile. The outcomes from this study evidenced that the developed technology produced suitable spray-dried powder to be employed as hard gelatin capsules for clinical trials. Conclusions: Although a traditional aqueous extract was the starting point of the work, the technological development of SDP was successfully achieved and transferred to the Brazilian pharmaceutical industry. Following Good Manufacturing Practices, this approach can provide efficient (and quickly) high-quality SDP and corresponding capsules for clinical evidence-based phytotherapy.
- 18 March 2025
- Published by MDPI AG in Preprints.org
Open AccessDevelopment of Monteverdia ilicifolia Spray-Dried Extract for a Clinical Trial: A Successful Scale-Up Experience with a Brazilian Native Plant
Background/Objectives: Our group has been trying to bring scientific rationale to the quality, safety and efficacy of Brazilian medicinal plants. This work was the first step of a broader project evaluating the potential of Monteverdia ilicifolia capsules for managing dyspepsia in a randomized, double-blind clinical trial. M. ilicifolia is a native species widely used in Brazilian traditional medicine for treating gastric disturbances. The central aim of the present work was to develop capsules containing an M. ilicifolia standardized spray-dried extract (SDP) on a lab scale and to transfer the process to a Brazilian pharmaceutical industry for a scale-up approach, achieving high-quality capsule production for our clinical trial Methods: Quality control of raw materials and derivative products followed the official plant monograph, specifically total tannin content (Folin-Dennis method) and epicatechin content (HPLC analysis). The leaves of M. ilicifolia were used to prepare an infusion for 15 minutes. The infusion was filtered and concentrated, and cornstarch and colloidal silicon dioxide were added to produce a M. illicifolia spray-dried powder, which was subsequently encapsulated. Results: The raw material and SDP had high total tannins and epicatechin content. The number of capsules required to achieve 860 mg of SDP was three capsules size 0. Due to the blind tests, the dose of 400 mg and the omeprazole (20 mg) were also encapsulated in three capsules size 0. The capsules prepared on a semi-industrial scale showed an immediate release profile. The outcomes from this study evidenced that the developed technology produced suitable spray-dried powder to be employed as hard gelatin capsules for clinical trials. Conclusions: Although a traditional aqueous extract was the starting point of the work, the technological development of SDP was successfully achieved and transferred to the Brazilian pharmaceutical industry. Following Good Manufacturing Practices, this approach can provide efficient (and quickly) high-quality SDP and corresponding capsules for clinical evidence-based phytotherapy.
- 24 February 2025
- Published by Magnolia Press in Phytotaxa
- Vol. 689 (2) , 163-184
Towards a better understanding of the Chromolaena congesta complex (Asteraceae, Eupatorieae): updated synopsis with taxonomic novelties
Taxonomic treatments for species complexes are a continuing challenge, in which new information and further questions are constantly being formulated. Regarding the Chromolaena congesta complex, recent studies with morphological data, geographic distribution and climatic niche have shed light on needed changes in the recognition and identification of some species. This paper presents a synopsis and an identification key of the species complex, which now consists of 11 taxa. Taxonomic novelties presented in this paper include a new combination for Eupatorium caaguazuense var. nervosum, re-established from the synonymy of C. squarrulosa and now treated as a distinct species, and the description of a cryptic new species from Southern Brazil with unique morphological traits. Furthermore, we propose the synonymy of C. xylorhiza under C. ascendens and provide updated information regarding distribution and evaluation of conservation status for each species. Finally, we included some insights on further studies to be conducted in the C. congesta complex to answer questions that still hamper the taxonomy and systematics of these species.
- 24 February 2025
- Published by Magnolia Press in Phytotaxa
- Vol. 689 (2) , 163-184
Towards a better understanding of the Chromolaena congesta complex (Asteraceae, Eupatorieae): updated synopsis with taxonomic novelties
Taxonomic treatments for species complexes are a continuing challenge, in which new information and further questions are constantly being formulated. Regarding the Chromolaena congesta complex, recent studies with morphological data, geographic distribution and climatic niche have shed light on needed changes in the recognition and identification of some species. This paper presents a synopsis and an identification key of the species complex, which now consists of 11 taxa. Taxonomic novelties presented in this paper include a new combination for Eupatorium caaguazuense var. nervosum, re-established from the synonymy of C. squarrulosa and now treated as a distinct species, and the description of a cryptic new species from Southern Brazil with unique morphological traits. Furthermore, we propose the synonymy of C. xylorhiza under C. ascendens and provide updated information regarding distribution and evaluation of conservation status for each species. Finally, we included some insights on further studies to be conducted in the C. congesta complex to answer questions that still hamper the taxonomy and systematics of these species.
- Open Access
Nephroprotective Plant Species Used in Brazilian Traditional Medicine for Renal Diseases: Ethnomedical, Pharmacological, and Chemical Insights
The prevalence of kidney-related diseases has been increasing and has emerged globally as a leading cause of mortality, especially in developing countries where they are considered a neglected public health problem. Renal diseases are commonly progressive and may cause irreversible loss of organ function, eventually necessitating renal replacement therapy. Although different pharmaceuticals are considered for the treatment of these pathologies, the uncertain effectiveness and presence of adverse effects have generated a growing need for the development of novel nephroprotective compounds. Because many medicinal herbs are typically used in Brazilian folk medicine to prevent and cure kidney ailments, ethnomedicine may play a promising and strategic role in identifying and adding new potential molecules to the pharmacological arsenal. This review focuses on the use of plants and secondary metabolites belonging to different classes to treat renal diseases, associating the screened plant extracts with the bioactive components present in each species. Flavonoids and triterpenes are notable metabolites that have therapeutic potential. The putative pharmacological mechanisms related to nephroprotective properties are also discussed in in vitro and in vivo models, when available.
Open AccessNephroprotective Plant Species Used in Brazilian Traditional Medicine for Renal Diseases: Ethnomedical, Pharmacological, and Chemical Insights
The prevalence of kidney-related diseases has been increasing and has emerged globally as a leading cause of mortality, especially in developing countries where they are considered a neglected public health problem. Renal diseases are commonly progressive and may cause irreversible loss of organ function, eventually necessitating renal replacement therapy. Although different pharmaceuticals are considered for the treatment of these pathologies, the uncertain effectiveness and presence of adverse effects have generated a growing need for the development of novel nephroprotective compounds. Because many medicinal herbs are typically used in Brazilian folk medicine to prevent and cure kidney ailments, ethnomedicine may play a promising and strategic role in identifying and adding new potential molecules to the pharmacological arsenal. This review focuses on the use of plants and secondary metabolites belonging to different classes to treat renal diseases, associating the screened plant extracts with the bioactive components present in each species. Flavonoids and triterpenes are notable metabolites that have therapeutic potential. The putative pharmacological mechanisms related to nephroprotective properties are also discussed in in vitro and in vivo models, when available.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Rodriguésia
- Vol. 75, e00572023
Medicinal plants with popular names associated with manufactured drugs in Rio Grande do Sul state, Brazil
Medicinal plants used by the population in southern Brazil have been observed to be popularly referred to by the names of manufactured drugs. This study aimed to find a connection between the use of medicinal plant species with popular names associated with manufactured drugs and the actual biomedical system. A database regarding such medicinal plants was established based on thirty-four ethnobotanical studies undertaken in the state of Rio Grande do Sul, Brazil, and chemical and pharmacological information was collected from a scientific article database and crossed referenced to determine whether folk information was correlated. Thirty-one species with a total of twenty-five different popular names of manufactured drugs were found. The greatest number of popular names of manufactured drugs was for Alternanthera brasiliana with eight names, followed by Achillea millefolium with six. The therapeutic indication of the species used in the manufactured formulas was found to differ from the indications of popular use. However, the therapeutic indication of both were correlated for digestive disorders, as well as for popularly named phytotherapic species. Cultural adoption of popular names may be influenced by the biomedical system and the flow of knowledge arising from conventional medicine toward popular medicine.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Rodriguésia
- Vol. 75, e00572023
Open AccessMedicinal plants with popular names associated with manufactured drugs in Rio Grande do Sul state, Brazil
Medicinal plants used by the population in southern Brazil have been observed to be popularly referred to by the names of manufactured drugs. This study aimed to find a connection between the use of medicinal plant species with popular names associated with manufactured drugs and the actual biomedical system. A database regarding such medicinal plants was established based on thirty-four ethnobotanical studies undertaken in the state of Rio Grande do Sul, Brazil, and chemical and pharmacological information was collected from a scientific article database and crossed referenced to determine whether folk information was correlated. Thirty-one species with a total of twenty-five different popular names of manufactured drugs were found. The greatest number of popular names of manufactured drugs was for Alternanthera brasiliana with eight names, followed by Achillea millefolium with six. The therapeutic indication of the species used in the manufactured formulas was found to differ from the indications of popular use. However, the therapeutic indication of both were correlated for digestive disorders, as well as for popularly named phytotherapic species. Cultural adoption of popular names may be influenced by the biomedical system and the flow of knowledge arising from conventional medicine toward popular medicine.
- 30 November 2023
- Published by MS-Editions in Boletin Latinoamericano Y Del Caribe de Plantas Medicinales Y Aromaticas
- Vol. 22 (6) , 770-795
Medicinal plants for digestive disorders: Areview of ethnobotanical studies conducted in southern Brazil
This review focuses on plant species traditionally used in Rio Grande do Sul, Santa Catarina and Paraná states (southern Brazil) for the relief of digestive disorders. Fifty ethnobotanical studies were compiled, resulting in 384 species mentioned, of which those cited in common to every state were selected. The search retrieved 63 native species used to alleviate gastrointestinal disorders, distributed in 21 botanical families, mainly Asteraceae, Lamiaceae and Myrtaceae. The most cited species include Achyrocline satureioides(82%), Eugenia uniflora(70%), Baccharis crispa(46%), Psidium cattleyanum(36%), Solanum paniculatum(36%) and Monteverdia ilicifolia(34%). Scientific studies have corroborated their popular use for the relief the gastrointestinal disorders, but most of them are preclinical and mainly exploratory. In conclusion, the folk use of medicinal species with therapeutic purposes is widespread in southern Brazil, but further studies are needed to guarantee their efficacy and safety.
- 30 November 2023
- Published by MS-Editions in Boletin Latinoamericano Y Del Caribe de Plantas Medicinales Y Aromaticas
- Vol. 22 (6) , 770-795
Medicinal plants for digestive disorders: Areview of ethnobotanical studies conducted in southern Brazil
This review focuses on plant species traditionally used in Rio Grande do Sul, Santa Catarina and Paraná states (southern Brazil) for the relief of digestive disorders. Fifty ethnobotanical studies were compiled, resulting in 384 species mentioned, of which those cited in common to every state were selected. The search retrieved 63 native species used to alleviate gastrointestinal disorders, distributed in 21 botanical families, mainly Asteraceae, Lamiaceae and Myrtaceae. The most cited species include Achyrocline satureioides(82%), Eugenia uniflora(70%), Baccharis crispa(46%), Psidium cattleyanum(36%), Solanum paniculatum(36%) and Monteverdia ilicifolia(34%). Scientific studies have corroborated their popular use for the relief the gastrointestinal disorders, but most of them are preclinical and mainly exploratory. In conclusion, the folk use of medicinal species with therapeutic purposes is widespread in southern Brazil, but further studies are needed to guarantee their efficacy and safety.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Acta Botanica Brasilica
- Vol. 37
Morphometric studies suggest taxonomic changes in a species complex in Chromolaena (Asteraceae, Eupatorieae, Praxelinae)
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Acta Botanica Brasilica
- Vol. 37
Open AccessMorphometric studies suggest taxonomic changes in a species complex in Chromolaena (Asteraceae, Eupatorieae, Praxelinae)
- 1 January 2021
- Published by Springer Nature
- p. 401-416
An Overview of the Cultural and Popular Use of Baccharis
- 1 January 2021
- Published by Springer Nature
- p. 401-416
An Overview of the Cultural and Popular Use of Baccharis
- 1 June 2020
- Published by Elsevier in Biochemical Systematics and Ecology
- Vol. 90
Chemical and phylogenetic characterization of Guaco (Mikania laevigata; M. glomerata) germplasm
- 1 June 2020
- Published by Elsevier in Biochemical Systematics and Ecology
- Vol. 90
Chemical and phylogenetic characterization of Guaco (Mikania laevigata; M. glomerata) germplasm
- Open Access
- 1 June 2019
- Published by FapUNIFESP (SciELO) in Acta Botanica Brasilica
- Vol. 33 (2) , 269-282
Medicinal plants for the "nerves": a review of ethnobotanical studies carried out in South Brazil
Among the medicinal purposes for which plants have been used is the treatment of “nerves". The objective of this study was to search for species of plants used in the state of Rio Grande do Sul (South Brazil) for the relief of symptoms related to central nervous system (CNS) disorders. Twenty-seven ethnobotanical studies were compiled, in which a total of 94 species were cited. The five most cited species were Cymbopogon citratus (81.5 %), Melissa officinalis (77.7 %), Aloysia citriodora (66.6 %), Matricaria chamomilla (62.9 %) and Passiflora edulis (51.8 %). Scientific studies have corroborated the popular use of these plants as sedatives, but most studies are preclinical and very few have been clinical (M. chamomilla and M. officinalis), and these were mainly exploratory or were performed against placebo. In addition to efficacy data, there are also indications of toxicity for M. chamomilla and P. edulis. In conclusion, there is a great diversity of plant species used in the treatment of symptoms related to CNS disorders, and they are most frequently used as a sedative. Data indicate that M. officinalis possesses clinical efficacy in the treatment of symptoms associated with anxiety without signs of toxicity.
- 1 June 2019
- Published by FapUNIFESP (SciELO) in Acta Botanica Brasilica
- Vol. 33 (2) , 269-282
Open AccessMedicinal plants for the "nerves": a review of ethnobotanical studies carried out in South Brazil
Among the medicinal purposes for which plants have been used is the treatment of “nerves". The objective of this study was to search for species of plants used in the state of Rio Grande do Sul (South Brazil) for the relief of symptoms related to central nervous system (CNS) disorders. Twenty-seven ethnobotanical studies were compiled, in which a total of 94 species were cited. The five most cited species were Cymbopogon citratus (81.5 %), Melissa officinalis (77.7 %), Aloysia citriodora (66.6 %), Matricaria chamomilla (62.9 %) and Passiflora edulis (51.8 %). Scientific studies have corroborated the popular use of these plants as sedatives, but most studies are preclinical and very few have been clinical (M. chamomilla and M. officinalis), and these were mainly exploratory or were performed against placebo. In addition to efficacy data, there are also indications of toxicity for M. chamomilla and P. edulis. In conclusion, there is a great diversity of plant species used in the treatment of symptoms related to CNS disorders, and they are most frequently used as a sedative. Data indicate that M. officinalis possesses clinical efficacy in the treatment of symptoms associated with anxiety without signs of toxicity.